Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
20121.8k citationsVictor Chong, Jean‐François Korobelnik et al.profile →
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
Countries citing papers authored by Yuichiro Ogura
Since
Specialization
Citations
This map shows the geographic impact of Yuichiro Ogura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Ogura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Ogura more than expected).
This network shows the impact of papers produced by Yuichiro Ogura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Ogura. The network helps show where Yuichiro Ogura may publish in the future.
Co-authorship network of co-authors of Yuichiro Ogura
This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Ogura.
A scholar is included among the top collaborators of Yuichiro Ogura based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Yuichiro Ogura. Yuichiro Ogura is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Dugel, Pravin U., et al.. (2018). Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER. Investigative Ophthalmology & Visual Science. 59(9). 1455–1455.2 indexed citations
5.
Lee, Won Ki, Yuichiro Ogura, Tomohiro Iida, et al.. (2017). Efficacy and Safety of Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy: 12-Month Results of the PLANET Study. Investigative Ophthalmology & Visual Science. 58(8). 1199–1199.3 indexed citations
6.
Hirahara, Shuichiro, et al.. (2016). Evaluation of choroidal circulatory disturbance with Ultra-Wide field Indocyanine Green Angiography. Investigative Ophthalmology & Visual Science. 57(12). 1649–1649.1 indexed citations
7.
Kato, Aki, et al.. (2016). Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration. SHILAP Revista de lepidopterología.7 indexed citations
8.
Kato, Aki, Ari Shinojima, Miki Sawa, et al.. (2015). A Multicenter Randomized Controlled Study of Antioxidant Supplementation with Lutein for the Treatment of Chronic Central Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science. 56(7). 167–167.1 indexed citations
Holz, Frank G., Yuichiro Ogura, Johann Roider, et al.. (2012). Intravitrial Aflibercept Injection for Macular Edema in Central Retinal Vein Occlusion: 1-year Results of the Phase 3 GALILEO Study. Investigative Ophthalmology & Visual Science. 53(14). 6929–6929.4 indexed citations
12.
Yasukawa, Tsutomu, et al.. (2011). The Impact Of Stop-smoking And Antioxidant Supplements On Patients With Chronic Central Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science. 52(14). 4511–4511.1 indexed citations
13.
Schmidt‐Erfurth, Ursula, Victor Chong, Bernd Kirchhof, et al.. (2011). Primary Results of an International Phase III Study Using Intravitreal VEGF Trap-Eye Compared to Ranibizumab in Patients with Wet AMD (VIEW 2). Investigative Ophthalmology & Visual Science. 52(14). 1650–1650.7 indexed citations
14.
Nagai, Hiroyuki, Yoshio Hirano, Munenori Yoshida, & Yuichiro Ogura. (2010). Incidence of the Complications After Intravitreal Injections. Investigative Ophthalmology & Visual Science. 51(13). 5120–5120.1 indexed citations
15.
Itaya, M., et al.. (2009). Non-Targeted siRNA Suppresses Laser-Induced Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 50(13). 1171–1171.3 indexed citations
16.
Ogura, Yuichiro, et al.. (2008). Development of a technique for capturing sleep Predictor signals during wakefulness. Journal of Optoelectronics and Advanced Materials. 10(5). 1251–1256.
17.
Yasukawa, Tsutomu, Peter Wiedemann, Johannes Kacza, et al.. (2007). Drusen Formation in a Three-Dimensional Culture System of Retinal Pigment Epithelial Cells. Investigative Ophthalmology & Visual Science. 48(13). 2177–2177.1 indexed citations
18.
Nozaki, Masahiro, et al.. (2003). Histopathological Evaluation after Radial Optic Neurotomy in Rabbit. Investigative Ophthalmology & Visual Science. 44(13). 2218–2218.1 indexed citations
19.
Mandai, Michiko, Masayo Takahashi, Hideki Miyamoto, et al.. (1998). Longterm effects of radiation treatment for age-related macular degeneration. 52(4). 567–571.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.